NewslettersHuman Immunology NewsUncategorizedPhase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate CancerBy Justin.choi - October 8, 2021013Stereotactic ablative radiotherapy induces anti-tumor immunity in clinical and preclinical studies, but immunological biomarkers are lacking.[Clinical Cancer Research] 6445218 {6445218:AAAAAAAA} apa 50 1 167638 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract